Fredric N. Eshelman, Director, 10% Owner at G1 Therapeutics, Inc. (GTHX), bought 3,439,151 shares at $15.00 ($4.5M) on 2017-05-22, disclosed to the SEC on 2017-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,139,151 | $0 | 0.0% |
| 2 | $15.00 | 300,000 | $4.5M | 100.0% |
| Total | $1.31 avg | 3,439,151 | $4.5M | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |